These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3007264)

  • 21. Effects of ketotifen and clenbuterol on beta-adrenergic receptor functions of lymphocytes and on plasma TXB-2 levels of asthmatic patients.
    Huszar E; Herjavecz I; Böszörmenyi-Nagy G; Slapke J; Schreiber J; Debreczeni LA
    Z Erkr Atmungsorgane; 1990; 175(3):141-6. PubMed ID: 1964319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaginal estriol administration in treatment of postmenopausal urinary incontinence].
    Schmidbauer CP
    Urologe A; 1992 Nov; 31(6):384-9. PubMed ID: 1462489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
    Pasotti C; Capra A; Vibelli C
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of the symptoms of urinary urge and urge incontinence with propiverin hydrochloride (Mictonorm)].
    Blau U; Retzke U
    Zentralbl Gynakol; 1984; 106(14):981-7. PubMed ID: 6506904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
    Boner AL; Sette L; Castellani C; Schiassi M
    J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle].
    Wehnert J; Sage S
    Z Urol Nephrol; 1989 May; 82(5):259-63. PubMed ID: 2665385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of asthma with a new sympathomimetic clenbuterol. Respiratory and Holter electrocardiographic surveillance].
    Pradalier A; Dry J; Canny M; Lionnet MY; Fabiani F
    Therapie; 1984; 39(6):671-6. PubMed ID: 6531740
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-up.
    Atan A; Konety BR; Erickson JR; Yokoyama T; Kim DY; Chancellor MB
    Tech Urol; 1999 Jun; 5(2):67-70. PubMed ID: 10458657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.
    Badawi JK; Langbein S
    Pharmazie; 2006 Mar; 61(3):175-8. PubMed ID: 16599254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effect of terodiline hydrochloride on pollakisuria and urinary incontinence].
    Sugiyama T; Kiwamoto H; Uchida A; Nagai N; Park YC; Kurita T; Ikegami M; Nakanishi A; Kawamura M; Umekawa T
    Hinyokika Kiyo; 1990 Nov; 36(11):1371-7. PubMed ID: 2288317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
    Brusasco V; Vibelli C; Chierichetti S; Ramoino R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):589-93. PubMed ID: 365800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of clenbuterol and prenalterol on behavior maintained under a multiple fixed-interval, fixed-ratio schedule.
    O'Donnell JM
    J Pharmacol Exp Ther; 1987 Aug; 242(2):588-94. PubMed ID: 2886645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity.
    Rajkumar GN; Small DR; Mustafa AW; Conn G
    BJU Int; 2005 Oct; 96(6):848-52. PubMed ID: 16153215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial.
    Wang AC; Chih SY; Chen MC
    Urology; 2006 Nov; 68(5):999-1004. PubMed ID: 17113893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the bladder a reliable witness for predicting detrusor overactivity?
    Hashim H; Abrams P
    J Urol; 2006 Jan; 175(1):191-4; discussion 194-5. PubMed ID: 16406907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of beta-adrenergic receptors and up-regulation of estrogen and progesterone receptors induced in the reproductive system of female veal calves by dietary clenbuterol.
    Re G; Badino P; Novelli A; Girardi C
    Am J Vet Res; 1995 Nov; 56(11):1493-7. PubMed ID: 8585662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity.
    Radley SC; Rosario DJ; Chapple CR; Farkas AG
    J Urol; 2001 Dec; 166(6):2253-8. PubMed ID: 11696746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.